Drug and Medication Industry: Benaroya Research Institute – Developmental Therapeutics Review – Q4 2010

• Publication date: December 2010

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Industry s Direct’s proprietary databases, Firms ’s corporate website, SEC filings, investor presentations and featured press releases, both from industry player and market -specific third party sources, put together by G...

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industry s Direct’s proprietary databases, Firms ’s corporate website, SEC filings, investor presentations and featured press releases, both from industry player and market -specific third party sources, put together by Global Industry s Direct’s team.

Scope of the Research

- Benaroya Research Institute - Brief industry player overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Benaroya Research Institute human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Benaroya Research Institute with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Benaroya Research Institute’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate Benaroya Research Institute’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Benaroya Research Institute in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Benaroya Research Institute’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Benaroya Research Institute.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Benaroya Research Institute and identify potential opportunities in those areas.

Global Therapy Industry

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Benaroya Research Institute Snapshot 4
Key Information 4
Key Facts 4
Benaroya Research Institute – Research and Development Overview 5
Key Therapeutic Areas 5
Benaroya Research Institute – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Combination Treatment Modalities 8
Benaroya Research Institute – Pipeline Products Glance 9
Benaroya Research Institute Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Benaroya Research Institute – Drug Profiles 10
Bevacizumab + Topotecan 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
CG8711 + docetaxel 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Docetaxel + CG1940/CG8711 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Docetaxel + ZD1839 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Gemcitabine + Docetaxel + Fluorouracil + Oxaliplatin + Alpha-Interferon + Radiation Therapy 14
Product Description 14
Mechanism of Action 14
R&D Progress 15
Benaroya Research Institute – Pipeline Analysis 16
Benaroya Research Institute – Pipeline Products by Therapeutic Class 16
Benaroya Research Institute Pipeline Products By Target 18
Benaroya Research Institute – Pipeline Products by Route of Administration 20
Benaroya Research Institute – Pipeline Products by Molecule Type 21
Benaroya Research Institute – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 24
Contact Us 24
Disclaimer 24List of Tables
Benaroya Research Institute – Pipeline by Therapy Area and Indication, 2010 6
Benaroya Research Institute – Pipeline by Stage of Development, 2010 7
Benaroya Research Institute – Combination Treatment Modalities in Pipeline, 2010 8
Benaroya Research Institute - Phase II, 2010 9
Benaroya Research Institute - Pipeline By Therapeutic Class, 2010 17
Benaroya Research Institute - Pipeline By Target, 2010 19
Benaroya Research Institute – Pipeline By Route of Administration, 2010 20
Benaroya Research Institute – Pipeline By Molecule Type, 2010 21

List of Figures
Benaroya Research Institute – Pipeline by Therapy Area and Indication, 2010 6
Benaroya Research Institute – Pipeline by Stage of Development, 2010 7
Benaroya Research Institute – Combination Treatment Modalities in Pipeline, 2010 8
Benaroya Research Institute – Pipeline By Therapeutic Class, 2010 16
Benaroya Research Institute - Pipeline By Target, 2010 18
Benaroya Research Institute – Pipeline By Route of Administration, 2010 20
Benaroya Research Institute – Pipeline By Molecule Type, 2010 21